Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
Ressources
Case study | 2023
Wrap-around services, Illegal drugs, Clinical guidance
The implementation and public health impacts of cannabis legalization in Canada: a systematic review
We provide a narrative summary of research on changes in cannabis arrests, cannabis products and prices, cannabis use and cannabis-related harm since legalization.
Lit review | 2023
Decriminalization/legalization, Policy/Regulatory
Commentary | 2023
Injecting drugs, Illegal drugs
Opioid analgesics are commonly used for acute low back pain and neck pain, but supporting efficacy data are scarce.
Original research | 2023
Chronic pain, Clinical guidance
The effectiveness of involuntary treatment using the mental health act or separate legislation for this purpose has not been revie
Lit review | 2023
Policy/Regulatory
This paper describes an interdisciplinary outpatient service developed during the COVID-19 pandemic to support and ensure continuity of care for patients with substance use and concurrent mental he
Case study | 2023
Transitions in care/treatment, Wrap-around services, Hospitals, Mental health
A narrative review of measures that have been developed to measure internalized stigma related to substance use in treatment settings
Lit review | 2023
Stigma
Commentary | 2023
Harm reduction, About prescribers
Our study aimed to characterize longitudinal substance use patterns among people receiving OAT and evaluate the association between different substance use patterns and the risk of OAT discontinuat
Original research | 2023
About PWUD, Illegal drugs, Stimulants, Substitution/OAT
Infographique | 2023
les jeunes, la mortalité, à propos des personnes qui utilisent des drogues, les transitions des soins / les transitions de traitement, le traitement de substitution/TAO
Infographic | 2023
Youth, Mortality, About PWUD, Transitions in care/treatment, Substitution/OAT
Report | 2023
Youth, Mortality, Transitions in care/treatment, Substitution/OAT, About PWUD
This rapid review aimed to synthesize available evidence on CBD as a potential harm reduction tool for people who use drugs while providing clinical and research insights.
Lit review | 2023
Harm reduction
This scoping review broadly aimed to map the literature on social vulnerability indices (SVIs).
Scoping review | 2023
Equity, Poverty
Accidental overdoses are now the leading cause of death among people with HIV (PWH) in British Columbia (BC). We examined the utilization and retention of opioid agonist therapy (OAT).
Original research | 2023
Substitution/OAT, About PWUD, Outcomes
The aim of this analysis was to explore the impact of safer supply programs on injection practices from the perspective of clients and providers in Ontario, Canada.
Original research | 2023
Injecting drugs, Evidence base, Safer supply, About PWUD, About prescribers
The aim of this scoping review is to explore nurse prescribing practices for medication-assisted treatment of opioid use disorder (MOUD) globally with a view to informing equitable access and polic
Scoping review | 2023
About prescribers, Policy/Regulatory
To explore the beliefs, values and perceptions of people who use substances (PWUS) around using and accessing virtual overdose monitoring services (VOMS) in Canada.
Original research | 2023
About PWUD, Digital health, Overdose, SCS/OPS
We explored patient perceptions of incorporating harm reduction supplies and education in hospital care with patients with opioid use disorder (OUD).
Original research | 2023
Harm reduction, Hospitals, About PWUD
